Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Tuberous Sclerosis 4Seizures 3Lennox Gastaut Syndrome 3Epilepsies, Myoclonic 3Anxiety Disorders 2Tuberous Sclerosis 2 1Tuberous Sclerosis 1 1Spasms, Infantile 1Prostatic Neoplasms 1Parasomnias 1Pain 1Neoplasms 1Nausea 1Marijuana Abuse 1Liver Cirrhosis 1Glioblastoma 1Epilepsy 1Colorectal Neoplasms 1Colonic Neoplasms 1Chemotherapy-Induced Peripheral Neuropathy 1Carcinoma, Intraductal, Noninfiltrating 1Cancer Pain 1Breast Neoplasms 1Breast Carcinoma In Situ 1Behavior 1

Interventions

Specimen Handling 8Tamoxifen 6Standard of Care 4Practice Guidelines as Topic 4Radiotherapy 3Methods 3Sentinel Lymph Node Biopsy 2Radiation Dose Hypofractionation 2Radiation 2Educational Status 2Early Intervention, Educational 2Counseling 2ruxolitinib 1pembrolizumab 1exemestane 1dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1abemaciclib 1Watchful Waiting 1Telemedicine 1Taxes 1Tablets 1Surveys and Questionnaires 1Starch 1Reverse Transcriptase Polymerase Chain Reaction 1Ranitidine 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Carcinoma In Situ × Cannabidiol × 1 year × Clear all
NCT06538389 2026-04-30

High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer

City of Hope Medical Center

Phase 2 Recruiting
36 enrolled
Breast

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡